Fetal doppler monitor, commonly known as baby heartbeat monitor, is a handheld ultrasound transducer used to detect the fetal heartbeat for prenatal care. Fetal doppler monitor provides information about the fetus, which is similar to that of fetal stethoscope, and it acts as an indicator of stress. The stress usually occurs during birth and labor period, which can be detected using the ultrasound probe and electrocardiography. Over the counter sale and use of Doppler ultrasound heartbeat monitors are used for listening to the heartbeat of a fetus. These are legally marketed as prescription devices and should be used under supervision of health care professionals. Doptone is a type of handheld portable ultrasound tool used for fetal monitoring. The tool is beneficial due to its waterproof technology. However, fetal monitoring increases the risk of C-section due to high rate of technological uses, which can develop many complications for the fetus and the mother during pregnancy.
Increase in number of childbirth, awareness program for preventing the complications in childbirth, and demand for at-home fetal heart monitors are important driving factors of the global fetal doppler monitoring system market. In 2014, the U.S. Food and Drug Administration declared the usage of Doppler ultrasound heartbeat monitors and fetal ultrasound imaging should be by trained health care professionals, and they are not intended for over the counter sale or use. Cost of treatment or ultrasonography and sensitivity of child toward ultrasound devices are expected to hamper the fetal doppler monitoring system market growth.
The global market has been segmented based on monitoring process type, end-user, and geography. In terms of monitoring process type, the fetal doppler monitoring system market is classified into electronic fetal monitoring, external fetal monitoring, and internal fetal monitoring. In terms of end-user, the market for fetal doppler monitoring system is classified into diagnostic laboratories, hospitals, and research & development. In terms of geography, the market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Geographically, North America dominates the global market due to increase in advent of technology of ultrasound monitoring devices and growth in child development plan. Early-phase diagnosis and treatment of disease during pregnancy is driving the medical biotechnology market which in turn is expected to drive the fetal doppler monitoring system market in North America. Europe is the second leading market for fetal doppler monitoring system as there are favorable government policies regarding health care infrastructure and awareness of population development. The Asia Pacific market is expected to grow at a higher rate due to rise in population, changing lifestyle, rise in awareness between patients, and increase in per capita expenditure. In addition, economic growth is supporting the health care infrastructure improvement in developing countries such as India and China.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20951
The major players operating in the global fetal doppler monitoring system market include Medline Industries, Inc., Bionet Co., Ltd, Huntleigh Healthcare Limited, Promed Group Co., Ltd., ELCAT, Hadeco, Inc., Shenzhen Biocare Bio-Medical Equipment Co., Ltd., Advanced Instrumentations, and SonoScape Medical Corp.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453